Aytu Biopharma (AYTU) FCF Margin (2013 - 2026)
Aytu Biopharma's FCF Margin was 27.28% in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 8.87 percentage points from 18.41% a year earlier and up 60.98 percentage points from the prior quarter.
Aytu Biopharma (AYTU) FCF Margin (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), FCF Margin at Aytu Biopharma came in at 5.65%, up 8.91 percentage points from FY2025.
- FCF Margin shows a five-year change of +48.83 percentage points (FY2021 to FY2026).
- In earlier fiscal years, FCF Margin was -3.26% in FY2025 (-0.63 pp), -2.63% in FY2024 (+2.14 pp), -4.78% in FY2023 (+25.04 pp) and -29.82% in FY2022 (+13.37 pp).
- The fiscal Q4 2026 figure marks the highest quarterly FCF Margin since fiscal Q4 2023.
- Compared with a year earlier, FCF Margin has increased for five straight quarters, with an average year-over-year change of +3.08 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was fiscal Q4 2023 (a gain of 56.34 percentage points); the worst was fiscal Q3 2022 (a drop of 183.78 percentage points).
- Per Business Quant data, AYTU's FCF Margin in the three fiscal quarters before Q4 2026 was -33.70% (Q3 2026), 24.12% (Q2 2026) and -4.45% (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Aytu Biopharma | 23.91 Mn | -91.77 Mn | 10.41 Mn | 27.28% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.28% |
| Mar 31, 2026 | -33.70% |
| Dec 31, 2025 | 24.12% |
| Sep 30, 2025 | -4.45% |
| Jun 30, 2025 | 18.41% |
| Mar 31, 2025 | -35.36% |
| Dec 31, 2024 | 17.87% |
| Sep 30, 2024 | -8.00% |
| Jun 30, 2024 | -7.65% |
| Mar 31, 2024 | -1.81% |
| Dec 31, 2023 | -0.72% |
| Sep 30, 2023 | -1.18% |
| Jun 30, 2023 | 30.49% |
| Mar 31, 2023 | -12.76% |
| Dec 31, 2022 | -9.33% |
| Sep 30, 2022 | -33.08% |
| Jun 30, 2022 | -25.85% |
| Mar 31, 2022 | -37.67% |
| Dec 31, 2021 | -38.11% |
| Sep 30, 2021 | -17.35% |
Aytu Biopharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();